Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.39 USD | -1.87% | -4.10% | -9.86% |
05-17 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
04-02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KALA BIO, INC. | Other Pharmaceuticals | -3.09% | -4.10% | -9.86% | -56.63% | -97.82% | 18.34M |
Technical Rankings Surperformance
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Comparison Chart